CIDOFOVIR FORMULATION FOR POSTEXPOSURE TREATMENT

Information

• Research Project
• 8350706

• ApplicationId

  8350706

• Core Project Number

  272200900015C-2-0-1

• Full Project Number

  272200900015C-2-0-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  8/15/2009 - 16 years ago

• Project End Date

  8/14/2014 - 11 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2011

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• Nanotherapeutics, Inc.

This contract supports the advanced development of cidofovir as a dry-powder formulation for the treatment of smallpox. The activities supported by this contract include preclinical and clinical development that fall into lead optimization and clinical candidate selection, IND-enabling activities;manufacturing activities;clinical activities;and animal study activities.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  155864

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:155864\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  NANOTHERAPEUTICS, INC.

• Organization Department

• Organization DUNS

  073438462

• Organization City

  ALACHUA

• Organization State

  FL

• Organization Country

  UNITED STATES

• Organization Zip Code

  326159403

• Organization District

  UNITED STATES